clorgyline has been researched along with Cardiovascular Stroke in 1 studies
Clorgyline: An antidepressive agent and monoamine oxidase inhibitor related to PARGYLINE.
clorgyline : An aromatic ether that is the 2,4-dichlorophenyl ether of 3-aminopropan-1-ol in which the nitrogen is substituted by a methyl group and a prop-1-yn-3-yl group. A monoamine oxidase inhibitor, it was formerly used as an antidepressant.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dănilă, MD | 1 |
| Privistirescu, AI | 1 |
| Mirica, SN | 1 |
| Sturza, A | 1 |
| Ordodi, V | 1 |
| Noveanu, L | 1 |
| Duicu, OM | 1 |
| Muntean, DM | 1 |
1 other study available for clorgyline and Cardiovascular Stroke
| Article | Year |
|---|---|
Acute inhibition of monoamine oxidase and ischemic preconditioning in isolated rat hearts: interference with postischemic functional recovery but no effect on infarct size reduction.
Topics: Animals; Clorgyline; Female; Ischemic Preconditioning, Myocardial; Male; Monoamine Oxidase Inhibitor | 2015 |